Vontobel Holding’s Fulgent Genetics FLGT Stock Holding History

Vontobel Holding’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,000	Closed	-$313K	–	1032
2020 Q4	$313K	Buy	+6,000	New	+$251K	﹤0.01%	791

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vontobel Holding's FLGT Position: Q1 2021 in Review

Vontobel Holding sold out of Fulgent Genetics (FLGT) in Q1 2021, closing a stake of 6,000 shares — an estimated $313K sold.

Vontobel Holding first reported a position in FLGT in Q4 2020 and held it in 1 quarter. The position peaked at $313K in Q4 2020. 256 funds tracked by Wall St. Rank hold FLGT as of Q1 2021.

Vontobel Holding reported no remaining Fulgent Genetics position as of Q1 2021 after selling out during the quarter.
Vontobel Holding sold 6,000 Fulgent Genetics shares in Q1 2021, an estimated $313K.
Vontobel Holding first reported a position in Fulgent Genetics in Q4 2020 and held it in 1 quarter.
Vontobel Holding's Fulgent Genetics position peaked at $313K in Q4 2020.
256 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2021.

Based on Vontobel Holding's 13F filing for Q1 2021, filed 11 May 2021.